Elsevier

Critical Care Clinics

Volume 31, Issue 4, October 2015, Pages 621-632
Critical Care Clinics

Diagnostic Criteria for Acute Kidney Injury: Present and Future

https://doi.org/10.1016/j.ccc.2015.06.001Get rights and content

Section snippets

Key points

  • The criteria for acute kidney are based on changes in serum creatinine and urine output. Standardized criteria, such as KDIGO criteria, allow for uniform implementation of guidelines and reliable estimates of incidence and outcomes.

  • However, acute kidney injury (AKI) remains a clinical diagnosis and clinical judgment is necessary to apply diagnostic criteria and to evaluate the changing clinical status of the patient.

  • Baseline renal function is also based on clinical judgment and is best

Criteria for acute kidney injury

Little progress was made in the understanding of AKI throughout the first two millennia ad. Although the term nephritis dates back to the sixteenth century it was not really until the late nineteenth century that Bright described renal failure (Bright disease) and included acute and chronic forms.4 A century later Bywaters and Beall described “acute renal failure” following crush injury.5 Throughout the remainder of the twentieth century, however, acute renal failure had no widely accepted

The purpose of standardized criteria for acute kidney injury

If AKI is clinical diagnosis, why are standard criteria desirable? The answer to this question comes in two parts. First, even though clinical judgment is required, a framework for the clinical diagnosis is needed. In general diagnoses are not based on pure speculation; clinicians consider a set of diagnostic features and use these to guide their judgment. These criteria are not “cook book” but they do serve as a frame of reference so that the average patient with the disease in question

Baseline renal function

A reference serum creatinine is used to apply the diagnostic criteria shown in Table 1 and to stage patients. When determining the most suitable reference creatinine, the first consideration is the timing of the acute illness believed to be the cause of the AKI. For example, in a patient admitted on Friday with unstable angina who then has three daily serum creatinine measures, all essentially the same, before undergoing cardiac surgery on Monday, there is a need to have a historical baseline

Serum creatinine and urine output

Older systems to classify AKI and non–renal-specific organ failure scores, such as the Sepsis-related Organ Failure Assessment,13 use fixed thresholds for serum creatinine (eg, 2.0 mg/dL) to classify renal “organ failure.” This approach is not appropriate for AKI for two reasons. First, normal creatinine may vary by two-fold depending on age, race, and sex (see Table 2). Second, a fixed creatinine does not distinguish between acute and chronic abnormalities. Thus, modern methods to quantify

Novel biomarkers

Over the last decade several novel biomarkers have been evaluated for their capacity to detect kidney damage and predict the development of AKI.27 Most novel markers were developed for their capacity to detect damage and as such they can provide additional insight into AKI, complementary to functional tests, such as serum creatinine and urine output.28 Note that the relationship between decreasing function and increasing damage is not as straightforward as might be assumed (Fig. 3). The

Diagnostic uncertainty and future classification systems

No diagnostic criteria based on serum creatinine and urine output will ever be perfect. Some patients will meet these criteria and not have AKI. For example, a vegetarian with a baseline serum creatinine of 0.4 mg/dL who develops a creatinine of 0.6 after a large protein load may not have any kidney abnormality at all. A patient with short-term dehydration will experience oliguria and yet kidney injury is unlikely in absence of underlying disease or acute nephrotoxic exposures (eg, myoglobin,

First page preview

First page preview
Click to open first page preview

References (39)

  • Kidney disease: improving global outcomes (KDIGO) clinical practice guideline for acute kidney injury work group (AKIWG)

    Kidney Int Suppl

    (2012)
  • E.G. Bywaters et al.

    Crush injuries with impairment of renal function

    Br Med J

    (1941)
  • R. Bellomo et al.

    Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

    Crit Care

    (2004)
  • R.L. Mehta et al.

    Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

    Crit Care

    (2007)
  • E.A.J. Hoste et al.

    RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis

    Crit Care

    (2006)
  • S. Uchino et al.

    An assessment of the RIFLE criteria for acute renal failure in hospitalized patients*

    Crit Care Med

    (2006)
  • F.E. Sileanu et al.

    AKI in low-risk versus high-risk patients in intensive care

    Clin J Am Soc Nephrol

    (2015)
  • J. Závada et al.

    AKI6 investigators: a comparison of three methods to estimate baseline creatinine for RIFLE classification

    Nephrol Dial Transplant

    (2010)
  • J.L. Vincent et al.

    The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

    Intensive Care Med

    (1996)
  • Cited by (55)

    View all citing articles on Scopus

    Disclosure: This work was supported in part by R01DK070910 and R01DK083961 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of NIDDK or National Institutes of Health.

    Competing Financial Interest: J.A. Kellum has received grant support and consulting fees from Alere, Astute Medical, Bard and numerous companies developing treatments for Acute Kidney Injury.

    View full text